Industry Research Reports
Home > Reports > Consumer Goods > Global Pet Parasiticide Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pet Parasiticide Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Consumer Goods
Published Date: 2025-11-17
Pages: 158 Pages
Report ld: 5482547
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Pet Parasiticide market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 163%.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Pet Parasiticide market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Boehringer Ingelheim
- Merck
- Virbac
- Vetoquinol
- Ceva Sante Animale
- HealthforAnimals
- BSAVA Sheldon Middleton
- Bayer
- Elanco
- Zoetis
- Chanelle
- Bimeda Animal Health
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Internal Parasites
- External Parasites
Segment by Application
- Online Sales
- Offline Sales
CHAPTER OUTLINE
Chapter 1: Defines the Pet Parasiticide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pet Parasiticide: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pet Parasiticide Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Internal Parasites
1.2.3 External Parasites
1.3 Market Segmentation by Application
1.3.1 Global Pet Parasiticide Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pet Parasiticide Revenue Estimates and Forecasts 2020-2031
2.2 Global Pet Parasiticide Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pet Parasiticide Sales Estimates and Forecasts 2020-2031
2.4 Global Pet Parasiticide Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pet Parasiticide Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pet Parasiticide Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Internal Parasites Market Size by Manufacturers
3.5.2 External Parasites Market Size by Manufacturers
3.6 Global Pet Parasiticide Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pet Parasiticide Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pet Parasiticide Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pet Parasiticide Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pet Parasiticide Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pet Parasiticide Sales and Revenue by Type (2020-2031)
6.4 North America Pet Parasiticide Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pet Parasiticide Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pet Parasiticide Sales and Revenue by Type (2020-2031)
7.4 Europe Pet Parasiticide Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pet Parasiticide Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pet Parasiticide Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pet Parasiticide Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pet Parasiticide Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pet Parasiticide Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pet Parasiticide Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pet Parasiticide Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pet Parasiticide Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pet Parasiticide Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pet Parasiticide Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Pet Parasiticide Product Models, Descriptions and Specifications
11.1.4 Boehringer Ingelheim Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boehringer Ingelheim Pet Parasiticide Sales by Product in 2024
11.1.6 Boehringer Ingelheim Pet Parasiticide Sales by Application in 2024
11.1.7 Boehringer Ingelheim Pet Parasiticide Sales by Geographic Area in 2024
11.1.8 Boehringer Ingelheim Pet Parasiticide SWOT Analysis
11.1.9 Boehringer Ingelheim Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Business Overview
11.2.3 Merck Pet Parasiticide Product Models, Descriptions and Specifications
11.2.4 Merck Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Merck Pet Parasiticide Sales by Product in 2024
11.2.6 Merck Pet Parasiticide Sales by Application in 2024
11.2.7 Merck Pet Parasiticide Sales by Geographic Area in 2024
11.2.8 Merck Pet Parasiticide SWOT Analysis
11.2.9 Merck Recent Developments
11.3 Virbac
11.3.1 Virbac Corporation Information
11.3.2 Virbac Business Overview
11.3.3 Virbac Pet Parasiticide Product Models, Descriptions and Specifications
11.3.4 Virbac Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Virbac Pet Parasiticide Sales by Product in 2024
11.3.6 Virbac Pet Parasiticide Sales by Application in 2024
11.3.7 Virbac Pet Parasiticide Sales by Geographic Area in 2024
11.3.8 Virbac Pet Parasiticide SWOT Analysis
11.3.9 Virbac Recent Developments
11.4 Vetoquinol
11.4.1 Vetoquinol Corporation Information
11.4.2 Vetoquinol Business Overview
11.4.3 Vetoquinol Pet Parasiticide Product Models, Descriptions and Specifications
11.4.4 Vetoquinol Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Vetoquinol Pet Parasiticide Sales by Product in 2024
11.4.6 Vetoquinol Pet Parasiticide Sales by Application in 2024
11.4.7 Vetoquinol Pet Parasiticide Sales by Geographic Area in 2024
11.4.8 Vetoquinol Pet Parasiticide SWOT Analysis
11.4.9 Vetoquinol Recent Developments
11.5 Ceva Sante Animale
11.5.1 Ceva Sante Animale Corporation Information
11.5.2 Ceva Sante Animale Business Overview
11.5.3 Ceva Sante Animale Pet Parasiticide Product Models, Descriptions and Specifications
11.5.4 Ceva Sante Animale Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Ceva Sante Animale Pet Parasiticide Sales by Product in 2024
11.5.6 Ceva Sante Animale Pet Parasiticide Sales by Application in 2024
11.5.7 Ceva Sante Animale Pet Parasiticide Sales by Geographic Area in 2024
11.5.8 Ceva Sante Animale Pet Parasiticide SWOT Analysis
11.5.9 Ceva Sante Animale Recent Developments
11.6 HealthforAnimals
11.6.1 HealthforAnimals Corporation Information
11.6.2 HealthforAnimals Business Overview
11.6.3 HealthforAnimals Pet Parasiticide Product Models, Descriptions and Specifications
11.6.4 HealthforAnimals Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 HealthforAnimals Recent Developments
11.7 BSAVA Sheldon Middleton
11.7.1 BSAVA Sheldon Middleton Corporation Information
11.7.2 BSAVA Sheldon Middleton Business Overview
11.7.3 BSAVA Sheldon Middleton Pet Parasiticide Product Models, Descriptions and Specifications
11.7.4 BSAVA Sheldon Middleton Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 BSAVA Sheldon Middleton Recent Developments
11.8 Bayer
11.8.1 Bayer Corporation Information
11.8.2 Bayer Business Overview
11.8.3 Bayer Pet Parasiticide Product Models, Descriptions and Specifications
11.8.4 Bayer Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Bayer Recent Developments
11.9 Elanco
11.9.1 Elanco Corporation Information
11.9.2 Elanco Business Overview
11.9.3 Elanco Pet Parasiticide Product Models, Descriptions and Specifications
11.9.4 Elanco Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Elanco Recent Developments
11.10 Zoetis
11.10.1 Zoetis Corporation Information
11.10.2 Zoetis Business Overview
11.10.3 Zoetis Pet Parasiticide Product Models, Descriptions and Specifications
11.10.4 Zoetis Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Zoetis Recent Developments
11.11 Chanelle
11.11.1 Chanelle Corporation Information
11.11.2 Chanelle Business Overview
11.11.3 Chanelle Pet Parasiticide Product Models, Descriptions and Specifications
11.11.4 Chanelle Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Chanelle Recent Developments
11.12 Bimeda Animal Health
11.12.1 Bimeda Animal Health Corporation Information
11.12.2 Bimeda Animal Health Business Overview
11.12.3 Bimeda Animal Health Pet Parasiticide Product Models, Descriptions and Specifications
11.12.4 Bimeda Animal Health Pet Parasiticide Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Bimeda Animal Health Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pet Parasiticide Industry Chain
12.2 Pet Parasiticide Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pet Parasiticide Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pet Parasiticide Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pet Parasiticide Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pet Parasiticide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pet Parasiticide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pet Parasiticide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pet Parasiticide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pet Parasiticide Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pet Parasiticide Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pet Parasiticide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Pet Parasiticide Sales by Region (2020-2025) & (Units)
Table 8. Global Pet Parasiticide Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pet Parasiticide Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Pet Parasiticide Sales Share by Manufacturers (2020-2025)
Table 12. Global Pet Parasiticide Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Pet Parasiticide Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Pet Parasiticide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Parasiticide as of 2024)
Table 16. Global Pet Parasiticide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Pet Parasiticide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Pet Parasiticide Manufacturing Base and Headquarters
Table 19. Global Pet Parasiticide Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Pet Parasiticide Sales by Type (2020-2025) & (Units)
Table 23. Global Pet Parasiticide Sales by Type (2026-2031) & (Units)
Table 24. Global Pet Parasiticide Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Pet Parasiticide Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Pet Parasiticide ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Pet Parasiticide Sales by Application (2020-2025) & (Units)
Table 29. Global Pet Parasiticide Sales by Application (2026-2031) & (Units)
Table 30. Pet Parasiticide High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Pet Parasiticide Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Pet Parasiticide Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Pet Parasiticide ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Pet Parasiticide Growth Accelerators and Market Barriers
Table 37. North America Pet Parasiticide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Pet Parasiticide Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Pet Parasiticide Growth Accelerators and Market Barriers
Table 40. Europe Pet Parasiticide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Pet Parasiticide Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Pet Parasiticide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Pet Parasiticide Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Pet Parasiticide Growth Accelerators and Market Barriers
Table 45. Southeast Asia Pet Parasiticide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Pet Parasiticide Investment Opportunities and Key Challenges
Table 47. Central and South America Pet Parasiticide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Pet Parasiticide Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Pet Parasiticide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Boehringer Ingelheim Corporation Information
Table 51. Boehringer Ingelheim Description and Major Businesses
Table 52. Boehringer Ingelheim Product Models, Descriptions and Specifications
Table 53. Boehringer Ingelheim Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Boehringer Ingelheim Sales Value Proportion by Product in 2024
Table 55. Boehringer Ingelheim Sales Value Proportion by Application in 2024
Table 56. Boehringer Ingelheim Sales Value Proportion by Geographic Area in 2024
Table 57. Boehringer Ingelheim Pet Parasiticide SWOT Analysis
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Merck Corporation Information
Table 60. Merck Description and Major Businesses
Table 61. Merck Product Models, Descriptions and Specifications
Table 62. Merck Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Merck Sales Value Proportion by Product in 2024
Table 64. Merck Sales Value Proportion by Application in 2024
Table 65. Merck Sales Value Proportion by Geographic Area in 2024
Table 66. Merck Pet Parasiticide SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Virbac Corporation Information
Table 69. Virbac Description and Major Businesses
Table 70. Virbac Product Models, Descriptions and Specifications
Table 71. Virbac Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Virbac Sales Value Proportion by Product in 2024
Table 73. Virbac Sales Value Proportion by Application in 2024
Table 74. Virbac Sales Value Proportion by Geographic Area in 2024
Table 75. Virbac Pet Parasiticide SWOT Analysis
Table 76. Virbac Recent Developments
Table 77. Vetoquinol Corporation Information
Table 78. Vetoquinol Description and Major Businesses
Table 79. Vetoquinol Product Models, Descriptions and Specifications
Table 80. Vetoquinol Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vetoquinol Sales Value Proportion by Product in 2024
Table 82. Vetoquinol Sales Value Proportion by Application in 2024
Table 83. Vetoquinol Sales Value Proportion by Geographic Area in 2024
Table 84. Vetoquinol Pet Parasiticide SWOT Analysis
Table 85. Vetoquinol Recent Developments
Table 86. Ceva Sante Animale Corporation Information
Table 87. Ceva Sante Animale Description and Major Businesses
Table 88. Ceva Sante Animale Product Models, Descriptions and Specifications
Table 89. Ceva Sante Animale Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Ceva Sante Animale Sales Value Proportion by Product in 2024
Table 91. Ceva Sante Animale Sales Value Proportion by Application in 2024
Table 92. Ceva Sante Animale Sales Value Proportion by Geographic Area in 2024
Table 93. Ceva Sante Animale Pet Parasiticide SWOT Analysis
Table 94. Ceva Sante Animale Recent Developments
Table 95. HealthforAnimals Corporation Information
Table 96. HealthforAnimals Description and Major Businesses
Table 97. HealthforAnimals Product Models, Descriptions and Specifications
Table 98. HealthforAnimals Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. HealthforAnimals Recent Developments
Table 100. BSAVA Sheldon Middleton Corporation Information
Table 101. BSAVA Sheldon Middleton Description and Major Businesses
Table 102. BSAVA Sheldon Middleton Product Models, Descriptions and Specifications
Table 103. BSAVA Sheldon Middleton Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. BSAVA Sheldon Middleton Recent Developments
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Major Businesses
Table 107. Bayer Product Models, Descriptions and Specifications
Table 108. Bayer Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Bayer Recent Developments
Table 110. Elanco Corporation Information
Table 111. Elanco Description and Major Businesses
Table 112. Elanco Product Models, Descriptions and Specifications
Table 113. Elanco Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Elanco Recent Developments
Table 115. Zoetis Corporation Information
Table 116. Zoetis Description and Major Businesses
Table 117. Zoetis Product Models, Descriptions and Specifications
Table 118. Zoetis Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Zoetis Recent Developments
Table 120. Chanelle Corporation Information
Table 121. Chanelle Description and Major Businesses
Table 122. Chanelle Product Models, Descriptions and Specifications
Table 123. Chanelle Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Chanelle Recent Developments
Table 125. Bimeda Animal Health Corporation Information
Table 126. Bimeda Animal Health Description and Major Businesses
Table 127. Bimeda Animal Health Product Models, Descriptions and Specifications
Table 128. Bimeda Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Bimeda Animal Health Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Parasiticide Product Picture
Figure 2. Global Pet Parasiticide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Internal Parasites Product Picture
Figure 4. External Parasites Product Picture
Figure 5. Global Pet Parasiticide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Online Sales
Figure 7. Offline Sales
Figure 8. Pet Parasiticide Report Years Considered
Figure 9. Global Pet Parasiticide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 11. Global Pet Parasiticide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Pet Parasiticide Revenue Market Share by Region (2020-2031)
Figure 13. Global Pet Parasiticide Sales (2020-2031) & (Units)
Figure 14. Global Pet Parasiticide Sales (CAGR) by Region (2020-2031) (Units)
Figure 15. Global Pet Parasiticide Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Pet Parasiticide Sales Volume Market Share in 2024
Figure 17. Global Pet Parasiticide Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Internal Parasites Revenue Market Share by Manufacturer in 2024
Figure 20. External Parasites Revenue Market Share by Manufacturer in 2024
Figure 21. Global Pet Parasiticide Sales Market Share by Type (2020-2031)
Figure 22. Global Pet Parasiticide Revenue Market Share by Type (2020-2031)
Figure 23. Global Pet Parasiticide Sales Market Share by Application (2020-2031)
Figure 24. Global Pet Parasiticide Revenue Market Share by Application (2020-2031)
Figure 25. North America Pet Parasiticide Sales YoY (2020-2031) & (Units)
Figure 26. North America Pet Parasiticide Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Pet Parasiticide Sales Revenue (US$ Million) in 2024
Figure 28. North America Pet Parasiticide Sales Volume (Units) by Type (2020- 2031)
Figure 29. North America Pet Parasiticide Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Pet Parasiticide Sales Volume (Units) by Application (2020-2031)
Figure 31. North America Pet Parasiticide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Pet Parasiticide Sales YoY (2020-2031) & (Units)
Figure 36. Europe Pet Parasiticide Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Pet Parasiticide Sales Revenue (US$ Million) in 2024
Figure 38. Europe Pet Parasiticide Sales Volume (Units) by Type (2020-2031)
Figure 39. Europe Pet Parasiticide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Pet Parasiticide Sales Volume (Units) by Application (2020-2031)
Figure 41. Europe Pet Parasiticide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 43. France Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Pet Parasiticide Sales YoY (2020-2031) & (Units)
Figure 48. Asia-Pacific Pet Parasiticide Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Pet Parasiticide Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Pet Parasiticide Sales Volume (Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Pet Parasiticide Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Pet Parasiticide Sales Volume (Units) by Application (2020-2031)
Figure 53. Asia-Pacific Pet Parasiticide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 58. India Pet Parasiticide Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Pet Parasiticide Sales YoY (2020-2031) & (Units)
Figure 60. Central and South America Pet Parasiticide Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Pet Parasiticide Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Pet Parasiticide Sales Volume (Units) by Type (2021-2031)
Figure 63. Central and South America Pet Parasiticide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Pet Parasiticide Sales Volume (Units) by Application (2020-2031)
Figure 65. Central and South America Pet Parasiticide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Pet Parasiticide Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Pet Parasiticide Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Pet Parasiticide Sales YoY (2020-2031) & (Units)
Figure 69. Middle East and Africa Pet Parasiticide Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Pet Parasiticide Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Pet Parasiticide Sales Volume (Units) by Type (2021-2031)
Figure 72. South America Pet Parasiticide Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Pet Parasiticide Sales Volume (Units) by Application (2020-2031)
Figure 74. Middle East and Africa Pet Parasiticide Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Pet Parasiticide Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Pet Parasiticide Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Pet Parasiticide Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Pet Parasiticide Revenue (2020-2025) & (US$ Million)
Figure 79. Pet Parasiticide Industry Chain Mapping
Figure 80. Regional Pet Parasiticide Manufacturing Base Distribution (%)
Figure 81. Global Pet Parasiticide Production Market Share by Region (2020-2031)
Figure 82. Pet Parasiticide Production Process
Figure 83. Regional Pet Parasiticide Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pet Parasiticide market?
The top companies in the global Pet Parasiticide market are Boehringer Ingelheim、Merck、Virbac.
Related Reports
Pet Parasiticide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pet Parasiticide was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 145
USD 3950.00
(Single User License)
Global Pet Parasiticide Market Research Report 2026
The global Pet Parasiticide market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-19
Pages: 126
USD 2900.00
(Single User License)
Global Pet Parasiticide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pet Parasiticide market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 95
USD 4250.00
(Single User License)
Pet Parasiticide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pet Parasiticide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-31
Pages: 120
USD 3950.00
(Single User License)
Global Pet Parasiticide Market Research Report 2025
The global market for Pet Parasiticide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-31
Pages: 95
USD 2900.00
(Single User License)
Pet Parasiticide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pet Parasiticide was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 145
USD 3950.00 (Single User License)Global Pet Parasiticide Market Research Report 2026
The global Pet Parasiticide market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-19
Pages: 126
USD 2900.00 (Single User License)Global Pet Parasiticide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pet Parasiticide market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 95
USD 4250.00 (Single User License)Pet Parasiticide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pet Parasiticide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-31
Pages: 120
USD 3950.00 (Single User License)Global Pet Parasiticide Market Research Report 2025
The global market for Pet Parasiticide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-31
Pages: 95
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now